Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
2003 5
2004 1
2006 1
2007 1
2008 2
2009 2
2011 2
2012 3
2013 2
2014 2
2016 5
2017 2
2018 3
2019 3
2020 4
2021 11
2022 6
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K; TRuE-V Study Group. Rosmarin D, et al. N Engl J Med. 2022 Oct 20;387(16):1445-1455. doi: 10.1056/NEJMoa2118828. N Engl J Med. 2022. PMID: 36260792
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Simpson EL, Sinclair R, Forman S, Wollenberg A, Aschoff R, Cork M, Bieber T, Thyssen JP, Yosipovitch G, Flohr C, Magnolo N, Maari C, Feeney C, Biswas P, Tatulych S, Valdez H, Rojo R. Simpson EL, et al. Among authors: aschoff r. Lancet. 2020 Jul 25;396(10246):255-266. doi: 10.1016/S0140-6736(20)30732-7. Lancet. 2020. PMID: 32711801 Free article. Clinical Trial.
Dokumentation der Psoriasis in der Routineversorgung - Expertenkonsens zu einem deutschen Datensatz.
Otten M, Mrowietz U, von Kiedrowski RM, Otto R, Altenburg A, Aschoff R, Beissert S, Beiteke U, Bonnekoh B, Hoffmann M, Körber A, Maaßen D, Mössner R, Navarini A, Petering H, Ramaker-Brunke J, Rosenbach T, Schwichtenberg U, Sticherling M, Sondermann W, Thaci D, Timmel A, Tsianakas A, Werfel T, Wilsmann-Theis D, Augustin M. Otten M, et al. Among authors: aschoff r. J Dtsch Dermatol Ges. 2021 Oct;19(10):1463-1477. doi: 10.1111/ddg.14547_g. J Dtsch Dermatol Ges. 2021. PMID: 34661349 German.
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere).
Simpson EL, Gooderham M, Wollenberg A, Weidinger S, Armstrong A, Soung J, Ferrucci S, Lima RG, Witte MM, Xu W, ElMaraghy H, Natalie CR, Pierce E, Blauvelt A; ADhere Investigators. Simpson EL, et al. JAMA Dermatol. 2023 Feb 1;159(2):182-191. doi: 10.1001/jamadermatol.2022.5534. JAMA Dermatol. 2023. PMID: 36630140 Free PMC article. Clinical Trial.
[Mucous membran diseases].
Laimer M, Aschoff R. Laimer M, et al. Among authors: aschoff r. Hautarzt. 2016 Oct;67(10):772-773. doi: 10.1007/s00105-016-3874-3. Hautarzt. 2016. PMID: 27613021 German. No abstract available.
[Seborrheic dermatitis].
Aschoff R, Kempter W, Meurer M. Aschoff R, et al. Hautarzt. 2011 Apr;62(4):297-307. doi: 10.1007/s00105-010-2119-0. Hautarzt. 2011. PMID: 21431920 Free article. German.
[Therapy of hypertrophic scars and keloids].
Aschoff R. Aschoff R. Hautarzt. 2014 Dec;65(12):1067-77; quiz 1078-9. doi: 10.1007/s00105-014-3546-0. Hautarzt. 2014. PMID: 25412721 Review. German.
Ein neunjähriger Junge mit lichenoiden Hautveränderungen.
Lehr S, Aschoff R, Blau K, Heil J, Heyne S, Beissert S, Günther C. Lehr S, et al. Among authors: aschoff r. J Dtsch Dermatol Ges. 2023 Jan;21(1):77-80. doi: 10.1111/ddg.14935_g. J Dtsch Dermatol Ges. 2023. PMID: 36721925 No abstract available.
54 results